The 10th International Congress on Cutaneous Adverse Drug Reactions, Shimane, Japan, 2018: Focus on New Discoveries

Drug Saf. 2019 Jun;42(6):797-801. doi: 10.1007/s40264-019-00818-1.

Cristina Olteanu¹, Neil H Shear^{2

3}, Eishin Morita⁴, Wen-Hung Chung^{5

6}, Hiroyuki Niihara⁴, Setsuko Matsukura^{7

8}, Rena Hashimoto⁹, Roni P Dodiuk-Gad^{10

11

12}

¹ Division of Dermatology, Department of Medicine, University of Alberta, Edmonton, AB, Canada.
² Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
³ Division of Clinical Pharmacology and Toxicology, Department of Medicine, University of Toronto, Toronto, ON, Canada.
⁴ Department of Dermatology, Shimane University Faculty of Medicine, Izumo, Japan.
⁵ Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospitals, Linkou, Taipei, Taiwan.
⁶ College of Medicine, Chang Gung University, Taoyüan, Taiwan.
⁷ Department of Dermatology, Saiseikai Yokohamashi Nanbu Hospital, Yokohama, Japan.
⁸ Department of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
⁹ Division of Dermatology, Keio University Hospital, Tokyo, Japan.
¹⁰ Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada. rdodiukgad@gmail.com.
¹¹ The Ruth and Bruce Rappaport Faculty of Medicine, Technion Institute of Technology, Haifa, Israel. rdodiukgad@gmail.com.
¹² Department of Dermatology, Emek Medical Centre, Afula, Israel. rdodiukgad@gmail.com.

No abstract available

Publication types